---
title: "Nurix Therapeutics Inc — Ownership Dossier"
canonical: https://whiteintel.dev/entity/2bf97e0f-c7cb-5e1d-bc02-696d155d1a3d
json: https://whiteintel.dev/api/public/dossier/2bf97e0f-c7cb-5e1d-bc02-696d155d1a3d
identifier: cusip:67080M103
jurisdiction: US
source: WhiteIntel corporate-ownership graph
---

# Nurix Therapeutics Inc

**Type:** Asset  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `cusip:67080M103`  
**Canonical dossier:** https://whiteintel.dev/entity/2bf97e0f-c7cb-5e1d-bc02-696d155d1a3d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/2bf97e0f-c7cb-5e1d-bc02-696d155d1a3d  

## Ownership & control

### UBO chain (walk to the ultimate owner)

A **129-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Provenance

- SEC 13F — https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Nurix Therapeutics Inc**. Human view: https://whiteintel.dev/entity/2bf97e0f-c7cb-5e1d-bc02-696d155d1a3d · Structured JSON: https://whiteintel.dev/api/public/dossier/2bf97e0f-c7cb-5e1d-bc02-696d155d1a3d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._